<DOC>
	<DOCNO>NCT02715713</DOCNO>
	<brief_summary>The primary goal pilot study investigate association testosterone deficiency presence abnormality function autonomic nervous system . If association exists , investigate effect testosterone replacement therapy correct abnormality .</brief_summary>
	<brief_title>Autonomic Manifestations Testosterone Deficiency Men</brief_title>
	<detailed_description>The investigator recruit 40 men age 40 80-years-old low testosterone . Participants select among male refer Texas Tech University Health Sciences Center 's ( TTUHSC 's ) Internal Medicine Endocrinology Division outpatient clinic study management testosterone deficiency TTUHSC Urology Department diagnosis management prostate cancer result testosterone deficiency due surgical pharmacological castration . After recruitment , patient initial standard clinical visit aspect fatigue anxiety investigate , follow full battery autonomic testing ( tilt table , heart rate response deep breathing , Valsalva , Quantitative Sudomotor Axon Reflex Test ( QSART ) . Those patient initial diagnosis testosterone deficiency initiate testosterone replacement ( intramuscular skin route ) standard care , follow second visit three ( 3 ) month -- normalization serum testosterone level -- evaluate change anxiety fatigue level , repeat cardiovascular autonomic function test . Those patient primary diagnosis prostate cancer normal serum testosterone level evaluate second time confirmation low testosterone , describe . Standard questionnaire use evaluate fatigue anxiety . The autonomic testing heart include tilt table ( tilt patient 70 degree special design table ) heart rate response deep breathing , Valsalva maneuver . Descriptive statistic compare treatment use different statistical method .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Inclusion Criteria first group : 1 . Patients testosterone deficiency ( total testosterone &lt; 277 ng/dL [ 9.6 nmol/L ] ) measure 710 , one symptom sign suggestive androgen deficiency mainly determine history . Reduced sexual desire ( libido ) Decreased spontaneous erection Breast discomfort , gynecomastia Loss body ( axillary pubic ) hair reduce shave Very small ( &lt; 5ml ) shrink testis Height loss Low trauma fracture Low bone mineral density Hot flush Sweats Decreased energy Decreased motivation Decreased initiative Decreased self confidence Feeling sad blue Depressed mood Dysthymia Poor concentration Poor memory Sleep disturbance Increased sleepiness 2 . Age 40 80 year Inclusion Criteria second group : 1 . Patients underwent chemical surgical castration prostatic cancer go receive androgen deprivation therapy . 2 . Age 40 80 year Exclusion Criteria ( group ) : 1 . Patients history current diagnosis : Atrial fibrillation . Cardiac arrythmia Pacemaker placement . Myocardial infarction &lt; 3 month Uncontrolled diabetes mellitus hemoglobin A1c &gt; 8.5 % last 6 month . Diabetes mellitus autonomic neuropathy Breast cancer Heart failure leave ventricular ejection fraction 35 % . Severe sleep apnea . Recent eye surgery ( &lt; 3 month ) Recent ischemic stroke ( &lt; 3 month ) History retinal detachment . History brain aneurysm . Severe chronic obstructive pulmonary disease ( COPD ) oxygen therapy . Intraocular hemorrhage lens dislocation . Glaucoma . Thyroid disease . Not literate English Exclusion Criteria patient receive testosterone treatment Metastatic prostate cancer Prostatespecific antigen ( PSA ) concentration &gt; 4.0 mcg/L , Prostatespecific antigen ( PSA ) &gt; 3.0 mcg/L highrisk men ( AfricanAmericans men firstdegree relative prostate cancer ) . ( Measured clinic visit 1 ) Polycythemia ( hemoglobin level &gt; 18 g/dL , hematocrit &gt; 52 % ) ( measure clinic visit 1 ) Severe acne . History venous arterial thrombosis . Persons literate English</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Autonomic neuropathy , Testosterone Deficiency</keyword>
</DOC>